Literature DB >> 23726220

Nucleotide excision repair in chronic neurodegenerative diseases.

Sara Sepe1, Cesar Payan-Gomez, Chiara Milanese, Jan H Hoeijmakers, Pier G Mastroberardino.   

Abstract

Impaired DNA repair involving the nucleotide excision repair (NER)/transcription-coupled repair (TCR) pathway cause human pathologies associated with severe neurological symptoms. These clinical observations suggest that defective NER/TCR might also play a critical role in chronic neurodegenerative disorders (ND), such as Alzheimer's and Parkinson's disease. Involvement of NER/TCR in these disorders is also substantiated by the evidence that aging constitutes the principal risk factor for chronic ND and that this DNA repair mechanism is very relevant for the aging process itself. Our understanding of the exact role of NER/TCR in chronic ND, however, is extremely rudimentary; while there is no doubt that defective NER/TCR can lead to neuronal death, evidence for its participation in the etiopathogenesis of ND is inconclusive thus far. Here we summarize the experimental observations supporting a role for NER/TCR in chronic ND and suggest questions and lines of investigation that might help in addressing this important issue. We also present a preliminary yet unprecedented meta-analysis on human brain microarray data to understand the expression levels of the various NER factors in the anatomical areas relevant for chronic ND pathogenesis. In summary, this review intends to highlight elements supporting a role of NER/TCR in these devastating disorders and to propose potential strategies of investigation.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; DNA damage; Huntington's disease; Neurodegeneration; Parkinson's disease; Transcriptomics

Mesh:

Year:  2013        PMID: 23726220     DOI: 10.1016/j.dnarep.2013.04.009

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  12 in total

Review 1.  R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy.

Authors:  Juliana Cuartas; Laxman Gangwani
Journal:  Front Cell Neurosci       Date:  2022-06-16       Impact factor: 6.147

2.  Activated or Impaired: An Overview of DNA Repair in Neurodegenerative Diseases.

Authors:  Nan Qin; Anke Geng; Renhao Xue
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

Review 3.  The central role of DNA damage in the ageing process.

Authors:  Björn Schumacher; Joris Pothof; Jan Vijg; Jan H J Hoeijmakers
Journal:  Nature       Date:  2021-04-28       Impact factor: 49.962

Review 4.  DNA repair diseases: What do they tell us about cancer and aging?

Authors:  Carlos Fm Menck; Veridiana Munford
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

Review 5.  Mechanisms of interstrand DNA crosslink repair and human disorders.

Authors:  Satoru Hashimoto; Hirofumi Anai; Katsuhiro Hanada
Journal:  Genes Environ       Date:  2016-05-01

6.  Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson's disease.

Authors:  Chiara Milanese; Silvia Cerri; Ayse Ulusoy; Simona V Gornati; Audrey Plat; Sylvia Gabriels; Fabio Blandini; Donato A Di Monte; Jan H Hoeijmakers; Pier G Mastroberardino
Journal:  Cell Death Dis       Date:  2018-07-26       Impact factor: 8.469

7.  Combination of Aβ Secretion and Oxidative Stress in an Alzheimer-Like Cell Line Leads to the Over-Expression of the Nucleotide Excision Repair Proteins DDB2 and XPC.

Authors:  Anne Forestier; Thierry Douki; Viviana De Rosa; David Béal; Walid Rachidi
Journal:  Int J Mol Sci       Date:  2015-07-30       Impact factor: 5.923

8.  Aging on a different scale--chronological versus pathology-related aging.

Authors:  Joost P M Melis; Martijs J Jonker; Jan Vijg; Jan H J Hoeijmakers; Timo M Breit; Harry van Steeg
Journal:  Aging (Albany NY)       Date:  2013-10       Impact factor: 5.682

9.  Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson's Disease.

Authors:  Sara Sepe; Chiara Milanese; Sylvia Gabriels; Kasper W J Derks; Cesar Payan-Gomez; Wilfred F J van IJcken; Yvonne M A Rijksen; Alex L Nigg; Sandra Moreno; Silvia Cerri; Fabio Blandini; Jan H J Hoeijmakers; Pier G Mastroberardino
Journal:  Cell Rep       Date:  2016-05-19       Impact factor: 9.423

10.  VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes.

Authors:  Elena Martín-Doncel; Ana M Rojas; Lara Cantarero; Pedro A Lazo
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.